Tardiff Daniel 4
4 · Camp4 Therapeutics Corp · Filed Dec 22, 2025
Insider Transaction Report
Form 4
Tardiff Daniel
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-12-11+145,500→ 145,500 totalExercise: $6.01Exp: 2035-12-10→ Common Stock (145,500 underlying)
Footnotes (1)
- [F1]This option has a vesting start date of December 1, 2025 and vests as to one third (33.33%) of the shares subject to the option on the first anniversary of the vesting start date and as to the remaining shares in equal monthly installments over 24 months thereafter, subject to continued service.